PHAMAZON OVERSEAS PVT. LTD.
Erlotinib

Erlotinib

Send Inquiry

Erlotinib

Rlotinib Hydrochloride  is a drug used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR). It is marketed in the United States by Genentech and OSI Pharmaceuticals and elsewhere by Roche.